As of: April 2026 — This article is updated whenever the legal situation changes. Last update: 05.04.2026.

Disclaimer: This article does not constitute legal advice. It serves solely as information. For binding assessments, consult a specialist lawyer in the respective country.

Austria has — similar to Germany — two relevant laws governing the regulation of research chemicals. The structure is comparable, but the details differ considerably in some areas.

The Narcotics Act (SMG)

The Austrian Narcotics Act (Suchtmittelgesetz) is the counterpart to Germany's BtMG. It regulates the handling of addictive substances, psychotropic substances, and precursor chemicals. LSD-25 is listed in the Narcotics Ordinance (SGV) and is therefore prohibited.

A significant difference from Germany: Austria has higher penalty ranges for commercial trade. According to Statistik Austria, approximately 38,500 reports under the SMG were filed in 2024 — an increase of 7% over the previous year.

The NPSG-AT (New Psychoactive Substances Act)

Austria has had its own NPS law since January 1, 2012 — four years before Germany's NpSG. The NPSG-AT was one of the first laws of its kind in Europe and takes a somewhat different approach than its German counterpart.

Key difference from the German NpSG: The Austrian NPSG-AT defines new psychoactive substances more broadly. The definition encompasses "substances and preparations that are intended or suitable to produce a psychoactive effect through ingestion" — and that do not already fall under the SMG.

The Austrian law also works with substance groups, but due to its broader base definition, it has a larger scope of coverage. In practice, this means: derivatives that are still legal in Germany may already be captured in Austria.

Status of LSD Derivatives in Austria (April 2026)

*Assessment based on the current substance-group definition. Binding information can only be provided by the Austrian Ministry of Health or a specialist lawyer.

Specifics in Austria

1. The Ministry of Health can react faster than the German legislator — a regulatory amendment suffices, no parliamentary vote needed
2. Personal use is handled differently: "health-related measures" instead of punishment (principle of "therapy instead of punishment")
3. Shipping from Germany to Austria is generally possible, as long as the derivative is legal in both countries
4. Customs checks at the DE-AT border practically don't exist (Schengen), but spot checks are possible

Switzerland is not an EU member and takes its own, generally more conservative approach to regulating research chemicals. Those conducting research in Switzerland need to know different laws.

The Narcotics Act (BetmG)

The Swiss BetmG regulates the handling of narcotics and psychotropic substances. It is supplemented by the Narcotics Schedule Ordinance (BetmVV-EDI), which specifically lists which substances are regulated.

No Separate NPS Law — But Rapid Ban Lists

Unlike Germany and Austria, Switzerland has no separate NPS law. Instead, new psychoactive substances are directly added to the existing BetmG schedules. This is faster because only a regulatory amendment is needed.

According to the Swiss Federal Office of Public Health (BAG), 23 new substances were added to the ban lists in 2025 alone — including several lysergamides.

Status of LSD Derivatives in Switzerland (April 2026)

Important: In Switzerland, the status of 1BP-LSD and 1Fe-LSD is not as clear-cut as in Germany. The BAG can also evaluate substances retroactively, and the broader definition in Swiss law leaves more room for interpretation. We strongly recommend checking with the BAG or a Swiss lawyer before placing any order.

Specifics in Switzerland

1. Faster regulation: Switzerland typically bans derivatives 6-12 months earlier than Germany
2. No risk-free Schengen border crossing: Switzerland conducts customs checks more frequently than within the EU
3. Possession is punishable: Unlike Germany's NpSG, possession under the Swiss BetmG is a criminal offense
4. Higher penalties: The Swiss BetmG provides for up to 20 years imprisonment in severe cases (for large-scale trade)
5. Cantonal differences: Prosecution varies considerably between cantons — Geneva and Zurich tend to be stricter than rural cantons

Germany to Austria

• Within the EU / Schengen — no systematic border controls
• As long as the derivative is legal in both countries: generally possible
• Risk: low, but not zero (spot checks on parcel services)
• Recommendation: Order from a vendor that explicitly ships to Austria

Germany to Switzerland

• Customs border! Every parcel can be inspected
• Swiss customs regularly check shipments for research chemicals
• Even if a derivative is legal in Germany, it may be banned in Switzerland
• Risk: considerable — we advise against cross-border shipping to Switzerland
• Recommendation: If possible, order from a Swiss vendor (provided the derivative is legal there)

Austria to Switzerland

• Same issue as Germany to Switzerland
• Customs border, inspections, different legal frameworks
• Risk: considerable

Personal Import vs. Vendor Orders

There is an important distinction between purchasing from a local vendor and personal importation. When you order from a German vendor that ships to Austria, the vendor bears responsibility for correct declaration. With personal importation (e.g., bringing items back from a trip), you are responsible yourself.

Within the EU, the rule is: Goods legally purchased in one EU country may generally be taken to another EU country — unless the destination country has independently banned the substance. With LSD derivatives, this is a real risk because the ban lists are not synchronized.

Legal Insurance and Research Chemicals

A topic rarely discussed: does your legal insurance cover a case related to research chemicals? The answer is in most cases: no. Most legal insurance policies in Germany, Austria, and Switzerland exclude "intentional criminal offenses." Even if the derivative was legal at the time of purchase, the insurer may argue that you knowingly accepted the risk of a legal change.

According to an analysis by the German Insurance Association (GDV, 2024), 73% of legal insurance providers reject cases related to psychoactive substances — regardless of whether the substance was legal at the time. This shows: prevention is better than insurance.

The 2027 Outlook

What will the DACH legal landscape look like a year from now? Predictions are difficult, but some trends are emerging:

• Germany: An NpSG amendment in the second half of 2026 or early 2027 is likely. The question is whether the new definition will be broad enough to capture organometallic compounds like 1Fe-LSD
• Austria: The BMSGPK established a working group on "novel psychoactive lysergamides" in February 2026 — an indication that regulation is in preparation
• Switzerland: The BAG is evaluating a "comprehensive update" of the BetmVV-EDI according to a media release from January 2026 — though the timeline is unclear

The three DACH countries have three different legal frameworks with different speeds, penalty ranges, and approaches. Germany currently offers the clearest situation for researchers, Austria is somewhat less defined, and Switzerland is the most restrictive of the three.